- Stocks
- Technology
- NASDAQ: CGNX

Price (delayed)

$48.22

Market cap

$8.36B

P/E Ratio

32.36

Dividend/share

$0.26

EPS

$1.49

Enterprise value

$8.22B

Cognex Corporation is an American manufacturer of machine vision systems, software and sensors used in automated manufacturing to inspect and identify parts, detect defects, verify product assembly, and guide assembly

The stock's price to earnings (P/E) is 36% less than its 5-year quarterly average of 50.4 and 26% less than its last 4 quarters average of 43.8

The quick ratio has grown by 14% from the previous quarter

The equity has declined by 2.8% year-on-year but it is up by 2.3% since the previous quarter

CGNX's debt is up by 41% year-on-year

The net income has contracted by 15% YoY and by 7% from the previous quarter

What are the main financial stats of CGNX

Market
Valuations
Earnings

Shares outstanding

173.4M

Market cap

$8.36B

Enterprise value

$8.22B

Price to earnings (P/E)

32.36

Price to book (P/B)

6.03

Price to sales (P/S)

7.7

EV/EBIT

27.52

EV/EBITDA

25.82

EV/Sales

7.57

Revenue

$1.09B

EBIT

$298.65M

EBITDA

$318.35M

Free cash flow

$192.81M

Per share
Balance sheet
Liquidity

EPS

$1.49

Free cash flow per share

$1.11

Book value per share

$8

Revenue per share

$6.26

TBVPS

$9.76

Total assets

$1.94B

Total liabilities

$553.1M

Debt

$34.25M

Equity

$1.39B

Working capital

$542.52M

Debt to equity

0.02

Current ratio

3.82

Quick ratio

2.77

Net debt/EBITDA

-0.45

Margins
Efficiency
Dividend

EBITDA margin

29.3%

Gross margin

71.3%

Net margin

23.8%

Operating margin

27.3%

Return on assets

13%

Return on equity

18.2%

Return on invested capital

21.5%

Return on capital employed

17.1%

Return on sales

27.5%

Dividend yield

0.53%

DPS

$0.26

Payout ratio

17.1%

How has the Cognex stock price performed over time

Intraday

-0.54%

1 week

0.58%

1 month

10.8%

1 year

-41.11%

YTD

-37.99%

QTD

13.41%

How have Cognex's revenue and profit performed over time

Revenue

$1.09B

Gross profit

$774.22M

Operating income

$295.94M

Net income

$258.67M

Gross margin

71.3%

Net margin

23.8%

CGNX's net margin is down by 23% year-on-year and by 7% since the previous quarter

The company's operating margin fell by 18% YoY and by 9% QoQ

The net income has contracted by 15% YoY and by 7% from the previous quarter

The revenue is up by 10% year-on-year

What is Cognex's growth rate over time

What is Cognex stock price valuation

P/E

32.36

P/B

6.03

P/S

7.7

EV/EBIT

27.52

EV/EBITDA

25.82

EV/Sales

7.57

The stock's price to earnings (P/E) is 36% less than its 5-year quarterly average of 50.4 and 26% less than its last 4 quarters average of 43.8

The EPS has contracted by 14% YoY and by 6% from the previous quarter

The price to book (P/B) is 31% lower than the last 4 quarters average of 8.7 and 26% lower than the 5-year quarterly average of 8.1

The equity has declined by 2.8% year-on-year but it is up by 2.3% since the previous quarter

The stock's price to sales (P/S) is 38% less than its 5-year quarterly average of 12.4 and 34% less than its last 4 quarters average of 11.7

The revenue is up by 10% year-on-year

How efficient is Cognex business performance

The ROS has contracted by 20% YoY and by 9% from the previous quarter

CGNX's return on invested capital is down by 17% year-on-year and by 9% since the previous quarter

Cognex's ROE has decreased by 17% YoY and by 6% from the previous quarter

The company's return on assets fell by 17% YoY and by 6% QoQ

What is CGNX's dividend history

DPS

$0.26

Dividend yield

0.53%

Payout ratio

17.1%

Recent dividends

How did Cognex financials performed over time

The quick ratio has grown by 14% from the previous quarter

The current ratio has grown by 13% YoY and by 11% from the previous quarter

CGNX's debt is 98% smaller than its equity

CGNX's debt is up by 41% year-on-year

CGNX's debt to equity is down by 33% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.